Form D · Other
BlueSphere Bio, Inc.
Pittsburgh, PA · CIK 0001754734
Offering snapshot reported Dec 29, 2020 · SEC filing
- Reported sold
- $45.6M Offering amount: $106M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2020 | Initial | $45,637,472 | No comparison | 1 | SEC filing |
| Oct 1, 2018 | Initial | $10,000,016 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-384524
The Total Offering Amount and the Total Amount Sold includes the conversion of $2,893,226.14 of outstanding convertible securities.
Source: Form D, filed Dec 29, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Apelian | Director, Executive |
| Jeanne Cunicelli | Director |
| Tal Heppenstall | Director |
| Alan Korman | Director |
| Robert Lin | Director |
| Warren Shlomchik | Executive |
| Mark Shlomchik | Director |
Issuer details
Industry: Other (See others in industry)
Address:
350 Technology Drive, Suite 510
Pittsburgh, PA, 15219
Pittsburgh, PA, 15219